For patients following The 30-Week Tirzepatide Reset, adding tesamorelin to a retatrutide regimen requires careful timing, especially with PCOS or other hormonal imbalances. Tesamorelin stimulates natural growth hormone release from the pituitary, which supports fat metabolism, improves insulin sensitivity, and helps regulate cortisol. Clinical data shows it reduces visceral fat by 15-20% over 26 weeks in patients with metabolic syndrome. When layered with retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, the combination can amplify fat loss while addressing the hypothalamic-pituitary disruptions common in PCOS.
The strongest evidence points to nighttime administration of tesamorelin, ideally within 30-60 minutes of bedtime on an empty stomach. Growth hormone pulses occur primarily during deep sleep, peaking between 1-3 AM. Studies in the Journal of Clinical Endocrinology & Metabolism demonstrate that evening dosing increases IGF-1 levels by 25-30% more effectively than morning injections. For CFP patients with PCOS, this timing helps reset disrupted luteinizing hormone pulses and lowers elevated androgens. In our clinic, women using this protocol alongside low-dose retatrutide cycling report fewer night sweats, better morning energy, and measurable drops in fasting insulin within 8 weeks.
Morning tesamorelin can blunt natural cortisol rhythms and interfere with retatrutide's appetite-suppressing effects during the day. Patients with hormonal imbalances often experience afternoon fatigue or disrupted sleep when dosed early. Our 30-week protocol specifically schedules tesamorelin at night during the second 70-day cycle to align with the body's repair window. We pair it with our Brown Detox Drops to clear endocrine disruptors that exacerbate PCOS symptoms. Japanese-style walking intervals in the morning further enhance insulin sensitivity without overtaxing joints that commonly ache in this population.
Begin with 1 mg tesamorelin at night while maintaining the lectin-free, low-carb meals outlined in the book. Track body composition weekly and monitor labs at weeks 4, 12, and 26. Most women with PCOS see androgen levels normalize and menstrual cycles regulate by week 18. Avoid high-dose continuous use; cycle off after 12 weeks to prevent receptor downregulation. This strategic integration prevents the two biggest mistakes: medication dependency without metabolic repair and ignoring non-scale victories like reduced joint pain and stable blood sugar. Patients like our clinic success stories regain metabolic freedom, losing 35-65 pounds while reversing hormonal imbalances that once made weight loss feel impossible.